Comparison Chart AstraZeneca Pharma India Limited

Equities

Market Closed - Bombay S.E. Other stock markets 06:00:48 2024-05-10 am EDT			5-day change	1st Jan Change
5,258 ^INR	+2.46%		-3.06%	-4.74%

Apr. 08	AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	CI
Mar. 25	AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ASTRAZENECA PHARMA INDIA LIMITED	Other Pharmaceuticals	+2.46%	-3.06%	-4.74%	+59.33%	+137.22%	1.57B